Immunosuppressive therapy with cyclosporine for cardiac transplantation.
- 1 January 1987
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 75 (1) , 40-56
- https://doi.org/10.1161/01.cir.75.1.40
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- IMMUNOREGULATORY MECHANISMS IN CYCLOSPORINE-TREATED RENAL ALLOGRAFT RECIPIENTSTransplantation, 1987
- Nephrotoxicity of CyclosporineNew England Journal of Medicine, 1985
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- Effects of trifluoperazine, a calmodulin antagonist, on rabbit T- and B-cell responses to mitogens and antigenCellular Immunology, 1984
- CYCLOSPORINE DOES NOT PREVENT CYTOPLASMIC CALCIUM CHANGES ASSOCIATED WITH LYMPHOCYTE ACTIVATIONTransplantation, 1984
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983
- Spontaneous Release of Interleukin-2 by Lung T Lymphocytes in Active Pulmonary SarcoidosisNew England Journal of Medicine, 1983
- Cyclosporin A: correlation between HPLC and RIA serum levelsInternational Journal of Clinical Pharmacy, 1982
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979